SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-156745
Filing Date
2024-06-07
Accepted
2024-06-07 08:32:32
Documents
13
Period of Report
2024-06-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d850099d8k.htm   iXBRL 8-K 32048
  Complete submission text file 0001193125-24-156745.txt   150560

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pmvp-20240606.xsd EX-101.SCH 2844
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmvp-20240606_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmvp-20240606_pre.xml EX-101.PRE 10808
16 EXTRACTED XBRL INSTANCE DOCUMENT d850099d8k_htm.xml XML 3501
Mailing Address ONE RESEARCH WAY PRINCETON NJ 08540
Business Address ONE RESEARCH WAY PRINCETON NJ 08540 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39539 | Film No.: 241027470
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)